Makiko Abe
Impact in
- Nephrology top 10%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Diabetes Treatment and Management
- Pituitary Gland Disorders and Treatments
Papers in
-
- Blood Pressure and Hypertension Studies 10
- Heart Rate Variability and Autonomic Control 4
-
- Pituitary Gland Disorders and Treatments 3
- Co-authors
- Masao Toyoda (11 shared papers)Masaaki Miyauchi (8 shared papers)Tomoya Umezono (8 shared papers)Naoyuki Yamamoto (8 shared papers)Moritsugu Kimura (10 shared papers)Hisatomi Arima (24 shared papers)Mayuko Kato (7 shared papers)Takako Kobayashi (7 shared papers)
- Journals
- Hypertension Research (13 papers)Medicine (3 papers)Biomedicines (2 papers)BMJ Open (2 papers)Environmental Health and Preventive Medicine (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Makiko Abe
44 papers receiving 413 citations
Peers
Comparison fields: 5 of 68
- Nephrology 56
- Endocrinology, Diabetes and Metabolism 78
- Cardiology and Cardiovascular Medicine 65
- Family Practice 3
- Clinical Biochemistry 11
Countries citing papers authored by Makiko Abe
This map shows the geographic impact of Makiko Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Abe more than expected).
Fields of papers citing papers by Makiko Abe
This network shows the impact of papers produced by Makiko Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Abe. The network helps show where Makiko Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside Makiko Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 49 | |
| 2 | 2009 | 39 | |
| 3 | 2021 | 34 | |
| 4 | 2009 | 26 | |
| 5 | 2011 | 24 | |
| 6 | 2018 | 24 | |
| 7 | 2021 | 21 | |
| 8 | 2019 | 19 | |
| 9 | 2008 | 19 | |
| 10 | 2018 | 18 | |
| 11 | 2024 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2024 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2017 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 6 |
About Makiko Abe
Makiko Abe is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Nephrology and General Health Professions, having authored 48 papers that have together received 417 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (10 papers), Sodium Intake and Health (4 papers), Mobile Health and mHealth Applications (4 papers), Renal Diseases and Glomerulopathies (4 papers), Heart Rate Variability and Autonomic Control (4 papers), COVID-19 and Mental Health (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Adrenal and Paraganglionic Tumors (3 papers). The work is most often cited by research in Nephrology (56 citations), Endocrinology, Diabetes and Metabolism (78 citations), Cardiology and Cardiovascular Medicine (65 citations), Family Practice (3 citations) and Clinical Biochemistry (11 citations). Makiko Abe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masao Toyoda, Masaaki Miyauchi, Tomoya Umezono, Naoyuki Yamamoto, Moritsugu Kimura, Hisatomi Arima, Mayuko Kato, Takako Kobayashi, Keiko Kobayashi and Daisuke Suzuki. Their work appears in journals such as Hypertension Research, Medicine, Biomedicines, BMJ Open and Environmental Health and Preventive Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.